首页> 外国专利> APPLICATION OF HONOKIOL AND MAGNOLOL IN PREPARING MCR-1 ENZYME INHIBITOR

APPLICATION OF HONOKIOL AND MAGNOLOL IN PREPARING MCR-1 ENZYME INHIBITOR

机译:HOPOKIOL和magnolol在制备MCR-1酶抑制剂中的应用

摘要

An application of honokiol and magnolol in preparing MCR-1 enzyme inhibitor. Moreover, by means of measurement of the minimal inhibitory concentration using a checkerboard method, an inhibition zone test, and a time-sterilization curve test, it is verified that honokiol and magnolol can inhibit the activity of an MCR-1 enzyme and restore the antibacterial activity of polymyxin B against MCR-1 positive enterobacteria (mainly comprising Escherichia coli and Klebsiella pneumoniae). Furthermore, by establishing a mouse thigh muscle infection model, it is proved that using honokiol and magnolol in combination with polymyxin B has a good therapeutic effect on infection caused by MCR-1 positive enterobacteria. Therefore, honokiol and magnolol, as MCR-1 inhibitors, can be used in combination with an antibiotic, which increases selectivity of drugs used for a super drug-resistant bacteria, and is of great significance for developing a new drug against MCR-1 positive enterobacteria infection.
机译:HOPIOL和MAGNOLOL在制备MCR-1酶抑制剂中的应用。此外,通过使用棋盘方法的最小抑制浓度的测量,抑制区试验和时间灭菌曲线试验,验证了HOMOKIOL和镁可以抑制MCR-1酶的活性并恢复抗菌性多粘蛋白B对MCR-1阳性细菌的活性(主要包含大肠杆菌和克雷布氏菌肺炎)。此外,通过建立小鼠大腿肌肉感染模型,证明使用HOPOKIOL和镁与MOLOMYXIN B组合具有良好的治疗效果,对MCR-1阳性肠杆菌引起的感染效果。因此,作为MCR-1抑制剂的HOMOKIOL和镁,可与抗生素组合使用,这增加了用于超级耐药细菌的药物的选择性,并且对于开发针对MCR-1阳性的新药具有重要意义细菌感染。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号